Cardiac Infarct
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). (NCT04433546) | PhaseBio Pharmaceuticals Inc. | 2020-07-15 |
| Feasibility of the "Heart-track" Rehabilitative Device Prototype (NCT04059627) | Tan Tock Seng Hospital | 2018-07-01 |
Track Cardiac Infarct automatically
Every clearance here is in the API, with alerts when new ones post.